Microplate Dx

Glasgow, United Kingdom · Founded 2021 · Privately Held (backing)

Developer of a medical diagnostic device designed to reduce deaths from drug-resistant infections. Microplate Dx is based in Glasgow, United Kingdom and was founded in 2021. It was valued at $11.9 million at its early-stage round in Sep 2025, the last priced event on record. It has raised $14 million across 2 recorded rounds; the latest was a $644,569 seed round in Sep 2025.

PMV mark · valuation
$11.9M
Oct 2026
Priced at
its early-stage round
Sep 2025
Total raised
$14.0M
Last round
Seed Round
Sep 2025
Cap table — not yet on record

Microplate Dx's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Microplate Dx with a free account
  • ·The complete investor list: 15 names
  • ·Watch Microplate Dx: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Microplate Dx

Where does Microplate Dx's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Microplate Dx's 2 recorded funding rounds.